College

Padmashri Dr. D.y.patil Institute Of Pharmaceutical Science And Research, Pimpri, Pune 411018

  • Overall Grade: not available yet
  • Private Un-Aided
  • Location: Pune, Maharashtra
  • No reviews yetWrite a review
#35 in Pharmacy (Government of India – NIRF 2025)

Updated

See my chances

Padmashri Dr. D.y.patil Institute Of Pharmaceutical Science And Research, Pimpri, Pune 411018 Admissions & Acceptance

Admissions

Entry to the four-year and six-year programmes is gated on a pharmacy entrance score rather than on board marks alone, and the institute names several tests as acceptable. Its B.Pharm page asks for a 10+2 pass with English, Physics and Chemistry plus either Mathematics or Biology, at least 45% in those subjects taken together, 40% for a reserved-category candidate, and a non-zero positive score in at least one pharmacy entrance examination such as MHT-CET, NEET or PERA CET. The Pharm.D page carries the same bar and adds a second qualifying route, a D.Pharm from an institution approved under section 12 of the Pharmacy Act. The diploma asks only for a regular science 10+2 with Physics, Chemistry and Biology or Mathematics. There is also a shorter way into the bachelor's, a three-year second-year entry the admission brochure lists as B.Pharm Direct Second Year, and it is used rather than merely advertised: the institute admitted 21, 22 and 22 lateral-entry students in the three years its ranking return covers. The brochure page headed eligibility criteria prints a duration against each programme and no entry condition against any of them, and the university's eligibility page sets out criteria for the diploma, the plain B.Pharm, the integrated B.Pharm with MBA, all three M.Pharm branches and both Pharm.D versions without listing the Direct Second Year at all. A diploma holder counting on that route should get the condition in writing rather than assume the usual one.

Postgraduate entry works on an interview, not on a rank list. For the M.Pharm the institute asks for a B.Pharm from any PCI-approved institute with at least 55% of marks and selects purely on a personal interview conducted by the university, with preference given to candidates holding a valid GPAT or PERA CET scorecard. The three-year Pharm.D (Post Baccalaureate) is filled the same way, on interview merit, with GPAT preferred. A GPAT score is therefore worth carrying here, but it does not admit you by itself, and a candidate without one is not shut out.

There is a university entrance test in the picture now, and the two DPGU pages that describe it disagree about whether pharmacy sits inside it. The DPAT page carries a downloadable syllabus for the degree side of the school, B.Pharm, the integrated B.Pharm with MBA, all three M.Pharm branches, the M.Sc., Pharm.D and the post-baccalaureate version, and put the pharmacy sitting at 11:15 am on Monday 17 August 2026, with registration closing at 3 pm on Saturday 15 August. The diploma, the AI diploma and the clinical-trials certificate are not on that syllabus list. The university's eligibility page names its own test as an acceptable score for the B.Tech, MBA, BBA and hospitality programmes, and for every pharmacy programme names only MHT-CET, NEET, PERA CET or another state or national pharmacy entrance. Both of those dates are behind us for this cycle. Ask which document governs the programme you want before you sit anything.

The change worth checking before you plan a cycle is which authority allots the seat. In 2024-25 the state carried three course rows against this institute, 0637582310 for B.Pharmacy with 100 seats, 0637582311T for 5 more, and 0637510010 for Pharm.D with 30, all under Savitribai Phule Pune University. On the CET Cell's current 2026-27 portal the same institute code carries no course rows at all. The cycle before that is the more telling one, because it ran to completion: this institute's name appears in neither the state's pharmacy seat matrix nor its CAP Round I cut-off merit list for that year, while its Akurdi namesake is in both. Both websites now point applicants at the same university admission office rather than at a CAP portal, so treat guidance built on state counselling for this campus as out of date and settle the route with that office before you pay a CET application fee.

One consequence of that shift is not settled by anything either party publishes: which university signs the degree. The Pharmacy Council's approval for the current session still names Savitribai Phule Pune University as the affiliating body for every degree programme and the state technical board for the diploma, while the fee sheet and the admission office are the new university's. Get the answer in writing before you pay, because the awarding university is what an employer and a registration council will eventually read.

Admissions Statistics

Seats

60

D.Pharm · PCI approved intake, 2025-2026 · Programme

Sanctioned (approved) intake

Academic yearUG [4 Years Program(s)]PG [2 Year Program(s)]PG [6 Years Program(s)]
2023-241004540
2022-231004540
2021-22100 Not published40
2020-21100 Not published30
2019-20 Not published Not published30
2018-19 Not published Not published30

First-year admissions

ProgrammeAcademic yearFirst-year intakeAdmitted
UG [4 Years Program(s)]2020-21100100
UG [4 Years Program(s)]2019-20100100
UG [4 Years Program(s)]2018-19100100
UG [4 Years Program(s)]2017-18 NIRF data 202410098
UG [4 Years Program(s)]2016-17 NIRF data 2023100100
PG [2 Years Program(s)]2022-234551
PG [2 Years Program(s)]2021-224548
PG [2 Years Program(s)]2020-214548
PG [2 Years Program(s)]2019-20 NIRF data 20244346
PG [2 Years Program(s)]2018-19 NIRF data 20234343
PG [6 Years Program(s)]2018-193029
PG [6 Years Program(s)]2017-1800
PG [6 Years Program(s)]2016-1700
PG [6 Years Program(s)]2015-16 NIRF data 202400
PG [6 Years Program(s)]2014-15 NIRF data 202300

Admitted through lateral entry

ProgrammeAcademic yearLateral entry
UG [4 Years Program(s)]2021-2222
UG [4 Years Program(s)]2020-2122
UG [4 Years Program(s)]2019-2021
UG [4 Years Program(s)]2018-19 NIRF data 202415
UG [4 Years Program(s)]2017-18 NIRF data 20233

Data source: NIRF data for Pharmacy only – data submitted for India Rankings 2025, 2024 and 2023

STUDENT POLLS


More opinions are needed to display this poll. Take our survey to add your opinion!

Cutoff

The most recent year in which the state published a closing figure against this institute is 2024-25, and those numbers are the only thresholds anyone has for it. The state prints them as a general merit number with the merit score, normally the MHT-CET percentile, in brackets behind it.

Seat category, CAP Round I, 2024-25B.Pharm closing merit numberPercentile
Open, home university285293.5346425
OBC, home university361692.1865451
Scheduled Caste, home university514889.7408207
Scheduled Tribe, home university1667073.9134477
Open ladies, home university173095.7134166
Open, other than home university105597.1651544

The six-year degree closed at a comparable level and, in one column, a much sharper one. Pharm.D took its open home-university seat at merit number 2775 on 93.6121346 and its open other-than-home seat at 543 on 98.3821558, so a candidate from outside the Pune university zone needed a percentile close to 98 for the clinical course while a Pune-zone candidate cleared it in the low nineties. That gap is the arithmetic of a small out-of-zone quota, not a difference in the class you would sit in.

Read it as a record of who the institute has been admitting, not as a line to clear next year: a seat filled by the university itself carries no published threshold, so the office is the only place that knows where the last intake ended.

Seat Matrix

Approved intake is set programme by programme by the Pharmacy Council of India, and the letter for the current session is published in full on the institute's site.

ProgrammeAffiliating bodyPCI approved intake, 2025-2026
D.PharmMaharashtra State Board of Technical Education60
B.PharmSavitribai Phule Pune University100
M.Pharm, PharmacologySavitribai Phule Pune University15
M.Pharm, Pharmaceutical Quality AssuranceSavitribai Phule Pune University15
M.Pharm, PharmaceuticsSavitribai Phule Pune University15
Pharm.DSavitribai Phule Pune University30
Pharm.D (Post Baccalaureate)Savitribai Phule Pune University10

How that B.Pharm hundred used to be divided is worth keeping, because it shows how much of the class was ever reachable through counselling. In the state's 2024-25 seat matrix the institute's Pharmacy course carried a sanctioned intake of 100 with 80 CAP seats, made up of 65 Maharashtra State seats and 15 All India seats, against 20 institute-level seats and 1 orphan-category seat, with no minority quota. One seat in five was always filled by the institute directly. With the CAP rows now empty, that direct route is the whole of it.

The university has since published its own coursewise intake for 2026-27, under which the School of Pharmacy and Research carries 75 B.Pharm seats, 25 on the B.Pharm with MBA, 60 in D.Pharm, 30 in Pharm.D and 10 in the post-baccalaureate version, 15 in each of the three M.Pharm specialisations and 15 in the M.Sc., with 30 on the AI diploma and 15 on the clinical-trials certificate. The bachelor's hundred survives that move but is split in two: the straight four-year degree is now smaller than the 100 the Pharmacy Council approved for the 2025-2026 session, and the balance has gone to the five-year MBA-integrated version. Anyone counting on a plain B.Pharm seat is competing for a shorter list than the approval letter suggests.

Will You Get Into Padmashri Dr. D.y.patil Institute Of Pharmaceutical Science And Research, Pimpri, Pune 411018?

Not available yet

Admissions Deadline & Due Dates

Not available yet

Admissions Requirements

Not available yet

Get recruited by colleges

Explore Admissions at Similar Colleges

How hard is it to get into Padmashri Dr. D.y.patil Institute Of Pharmaceutical Science And Research, Pimpri, Pune 411018?

Not available yet

Reviews About Admissions

Back to Full Profile